Skip to Main Content

January 14, 2022

Health Law Weekly

CMS Proposes Limited Medicare Coverage of Alzheimer’s Treatment

  • January 14, 2022

Medicare would cover a controversial treatment for Alzheimer’s disease only for patients who are enrolled in randomized controlled clinical trials under a proposed National Coverage Determination (NCD) issued by the Centers for Medicare & Medicaid Services (CMS) on January 11.

ARTICLE TAGS
  • Government Reimbursement

You must be logged in to access this content.